These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28130554)

  • 1. Effects of UVA1 Phototherapy on Expression of Human Endogenous Retroviral Sequence (HERV)-K10 gag in Morphea: A Preliminary Study.
    Kowalczyk MJ; Teresiak-Mikołajczak E; Dańczak-Pazdrowska A; Żaba R; Adamski Z; Osmola-Mańkowska A
    Med Sci Monit; 2017 Jan; 23():505-512. PubMed ID: 28130554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential role of human endogenous retrovirus K10 in the pathogenesis of rheumatoid arthritis: a preliminary study.
    Ejtehadi HD; Freimanis GL; Ali HA; Bowman S; Alavi A; Axford J; Callaghan R; Nelson PN
    Ann Rheum Dis; 2006 May; 65(5):612-6. PubMed ID: 16192292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultraviolet A1 phototherapy decreases inhibitory SMAD7 gene expression in localized scleroderma.
    Kreuter A; Hyun J; Skrygan M; Sommer A; Tomi NS; Breuckmann F; Altmeyer P; Gambichler T
    Arch Dermatol Res; 2006 Nov; 298(6):265-72. PubMed ID: 17009056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of selected human endogenous retroviral sequences in skin and peripheral blood mononuclear cells in morphea.
    Kowalczyk MJ; Dańczak-Pazdrowska A; Szramka-Pawlak B; Zaba R; Silny W; Osmola-Mańkowska A
    Arch Med Sci; 2012 Nov; 8(5):819-25. PubMed ID: 23185190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence of morphea after successful ultraviolet A1 phototherapy: A cohort study.
    Vasquez R; Jabbar A; Khan F; Buethe D; Ahn C; Jacobe H
    J Am Acad Dermatol; 2014 Mar; 70(3):481-8. PubMed ID: 24365168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human endogenous retroviral element K10 (HERV-K10) encodes a full-length gag homologous 73-kDa protein and a functional protease.
    Mueller-Lantzsch N; Sauter M; Weiskircher A; Kramer K; Best B; Buck M; Grässer F
    AIDS Res Hum Retroviruses; 1993 Apr; 9(4):343-50. PubMed ID: 8512750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human endogenous retroviruses and chosen disease parameters in morphea.
    Kowalczyk MJ; Dańczak-Pazdrowska A; Szramka-Pawlak B; Żaba R; Osmola-Mańkowska A; Silny W
    Postepy Dermatol Alergol; 2017 Feb; 34(1):47-51. PubMed ID: 28261031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medium-dose UVA1 phototherapy in localized scleroderma and its effect in CD34-positive dendritic cells.
    Camacho NR; Sánchez JE; Martin RF; González JR; Sánchez JL
    J Am Acad Dermatol; 2001 Nov; 45(5):697-9. PubMed ID: 11606918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human endogenous retrovirus K10: expression of Gag protein and detection of antibodies in patients with seminomas.
    Sauter M; Schommer S; Kremmer E; Remberger K; Dölken G; Lemm I; Buck M; Best B; Neumann-Haefelin D; Mueller-Lantzsch N
    J Virol; 1995 Jan; 69(1):414-21. PubMed ID: 7983737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultraviolet A1 phototherapy for the treatment of localized scleroderma.
    Furuhashi T; Torii K; Ikumi K; Kato H; Nishida E; Morita A
    J Dermatol; 2020 Jul; 47(7):792-795. PubMed ID: 32383187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful ultraviolet A1 phototherapy in the treatment of localized scleroderma: a retrospective and prospective study.
    Andres C; Kollmar A; Mempel M; Hein R; Ring J; Eberlein B
    Br J Dermatol; 2010 Feb; 162(2):445-7. PubMed ID: 19785603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultraviolet A1-induced downregulation of human beta-defensins and interleukin-6 and interleukin-8 correlates with clinical improvement in localized scleroderma.
    Kreuter A; Hyun J; Skrygan M; Sommer A; Bastian A; Altmeyer P; Gambichler T
    Br J Dermatol; 2006 Sep; 155(3):600-7. PubMed ID: 16911288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined treatment with calcipotriol ointment and low-dose ultraviolet A1 phototherapy in childhood morphea.
    Kreuter A; Gambichler T; Avermaete A; Jansen T; Hoffmann M; Hoffmann K; Altmeyer P; von Kobyletzki G; Bacharach-Buhles M
    Pediatr Dermatol; 2001; 18(3):241-5. PubMed ID: 11438008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of PUVA vs. UVA1 phototherapy in the treatment of morphea patients.
    Malewska-Woźniak A; Osmola-Mañkowska A; Adamski Z
    Postepy Dermatol Alergol; 2022 Aug; 39(4):757-761. PubMed ID: 36090739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of antibodies against HERV-K10 in patients with testicular cancer but not with AIDS.
    Goedert JJ; Sauter ME; Jacobson LP; Vessella RL; Hilgartner MW; Leitman SF; Fraser MC; Mueller-Lantzsch NG
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):293-6. PubMed ID: 10207631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human endogenous retrovirus-K10 protease in cell-free and cell-based assays.
    Kuhelj R; Rizzo CJ; Chang CH; Jadhav PK; Towler EM; Korant BD
    J Biol Chem; 2001 May; 276(20):16674-82. PubMed ID: 11278433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of selected genes of dendritic and Treg cells in blood and skin of morphea patients treated with UVA1 phototherapy.
    Osmola-Mańkowska AJ; Teresiak-Mikołajczak E; Kowalczyk MJ; Żaba RW; Adamski Z; Dańczak-Pazdrowska A
    Arch Med Sci; 2018 Mar; 14(2):361-369. PubMed ID: 29593811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological effects of a new ultraviolet A
    Arndt S; Lissner C; Unger P; Bäumler W; Berneburg M; Karrer S
    Exp Dermatol; 2020 Dec; 29(12):1199-1208. PubMed ID: 32592187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UVA irradiation induced heme oxygenase-1: a novel phototherapy for morphea.
    Nisar MF; Parsons KS; Bian CX; Zhong JL
    Photochem Photobiol; 2015; 91(1):210-20. PubMed ID: 25207998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for human endogenous retrovirus-K (HML-2) in rheumatoid arthritis: investigating mechanisms of pathogenesis.
    Freimanis G; Hooley P; Ejtehadi HD; Ali HA; Veitch A; Rylance PB; Alawi A; Axford J; Nevill A; Murray PG; Nelson PN
    Clin Exp Immunol; 2010 Jun; 160(3):340-7. PubMed ID: 20345981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.